Organigram Holdings Inc. Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending November 30, 2022 was 22.12% (a 12.46% increase compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -4.37%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2022 was 22.29% (a 68.74% increase from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 13.21% (a -9.77% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 14.64% (a -90.48% decrease from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending November 30, 2022 was 22.51% (a 0.99% increase compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -25.93% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
30 Nov '22 31 Aug '22 31 May '22 28 Feb '22
22.51% 22.29% 26.66% 30.39%
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of Organigram Holdings Inc.

Most recent Selling, General and Administrative (SG&A) Expenses Growthof OGI including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Organigram Holdings Inc.

Organigram Holdings Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 22.12% 19.67% 25.3% 23.13% 22.29%
2021 20.98% 38.23% 40.76% -18.49% 13.21%
2020 4.95% -29.84% -1.97% 59.26% 14.64%
2019 98.63% 42.54% 2.01% -37.21% 153.75%
2018 -49.65% 116.33%
2017 87.46%
2016 -46.65%

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic